Executive Summary
Hikma Pharmaceuticals filed an IPR against Axsome Malta’s 11,560,354 patent. The parties settled the dispute early and jointly moved to terminate the proceeding. The Board granted the motion and ordered the settlement agreement to be kept confidential.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in HIKMA PHARMACEUTICALS USA INC. vs Axsome Malta Ltd. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
HIKMA PHARMACEUTICALS USA INC.vsAxsome Malta Ltd. et al.
Hikma Pharmaceuticals and the patent owners filed a joint motion asking the PTAB to treat their settlement agreement as confidential business information, keeping it separate from the patent file. The request relies on 35 U.S.C. § 317(b) and related regulations.
The Integration Group of Americas, Inc.vsSitePro, Inc.
The Integration Group of Americas and SitePro entered a settlement that resolves all disputes over Patent No. 11,762,504, and jointly moved to terminate the pending IPR.
Samsung Electronics Co., Ltd. et al.vsWilus Institute of Standards and Technology Inc.
The USPTO denied Samsung's request for Director Review of the institution decisions in several IPRs involving Wilus's patent 11,159,210. The institution decisions remain in effect.
Suzhou Mojawa Intelligent Electronic Co., Ltd.vsShenzhen Shokz Co., Ltd.
Suzhou Mojawa challenges Shenzhen Shokz’s headset patent in an IPR. The petitioner argues the Patent Owner’s Director Review request fails to show any erroneous findings of fact, and the Acting Director’s referral was proper. The Board is urged to deny the request.
Dentsply Sirona Inc.vsOsseo Imaging, LLC
The PTAB instituted an inter partes review of Osseo Imaging’s dental densitometry patent covering claims 1‑24, finding a reasonable likelihood of unpatentability based on prior‑art references such as Arai and Pelc. Discretionary factors, including a stay in a related district‑court case, led the Board to reject a denial request.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.